课题基金 / 基金详情

COBRE: OK MED RES FOUND: CORE I: IN VITRO MICROSCOPY CORE

COBRE: OK MED RES FOUND: CORE I: IN VITRO MICROSCOPY CORE
COBRE:确定医学研究成果:核心 I:体外显微镜核心
批准号:
7382049
负责人:
FLOREA LUPU
金额:
$10.55万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2007-06-30
关键词:

项目摘要

项目成果

FLOREA LUPU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Advanced microscopy techniques represent major investigational approaches in each of the proposed projects of our multi-disciplinary program. The choice of the most appropriate method can be very complex, and the techniques involved in sample preparation require considerable skill. Therefore the In Vitro Microscopy Core will play a particularly important role in this collaborative program. The Core will provide state-of-the-art expertise in various steps of the projects, from experimental design and specimen preparation, to image capture and analysis of high-resolution light and electron micrographs. The In Vitro Microscopy Core will be based in the recently established Imaging Facility of the Cardiovascular Biology Research Program, under the direction of Dr. Florea Lupu. An experienced imaging specialist, Dr. Andrew Westmuckett will devote 50% of his effort towards the activities described in this proposal. The core has the expertise and the equipment to perform a diversity of techniques, ranging from brightfield histological analysis to confocal microscopy and 3D imaging, from standard transmission electron microscopy to immunogold labeling and advanced cryo-technologies (cryoimmunogold labeling, freeze substitution, high pressure freezing, and freeze fracture and deep-etching).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Complement C5 inhibition as sepsis therapy
Complement C5 inhibition as sepsis therapy
Discovery and Characterization of Novel Sepsis Proteome Biomarkers
Contact Activation and Infection
国内基金
海外基金
OSMI-4靶向O-糖基化调控PD-L1联合裂解OK-432协同治疗不完全消融后残存肝癌的机制研究
  • 批准号:
    JCZRLH202600261
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
mtlncRNA OK/SW-cl.16通过MEF2D-ND6通路介导肺腺癌顺铂耐药的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    杜贺
  • 依托单位:
肺淋巴管肌瘤病类器官分析 OK432治疗乳糜胸的机制研究
  • 批准号:
    2020A151501294
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2020
  • 负责人:
    邱源
  • 依托单位:
OK-432联合PD-1单抗治疗肝癌射频消融后残存和远处转移瘤的机制及疗效研究
  • 批准号:
    82072041
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2020
  • 负责人:
    阚雪锋
  • 依托单位: